CCR5 and neoplasm: We observed that exposure to Maraviroc reduces MDA-MB 231 chemotaxis induced by mammary fibroblast-conditioned media by 50% (Figure 5), thus indicating that CCR5 function contributes to tumor cell chemotaxis induced by mammary fibroblasts.